Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.38 is 163% below its 5-year average of -0.52, near the low end of its 5-year range (-1.38–0.00).
48.39% below its 12-month average of -0.93.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.03.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 14 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.38
EARNINGS PER SHARE (EPS) AVG TTM
-0.93
EARNINGS PER SHARE (EPS) AVG 3Y
-0.75
EARNINGS PER SHARE (EPS) AVG 5Y
-0.52
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-48.39%
CURRENT VS 3Y AVG
-84.62%
CURRENT VS 5Y AVG
-163.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MIRA Pharmaceuticals, Inc.
Market Cap
$30.69M
Earnings Per Share (EPS)
-1.38
TTM Avg
-0.93
3Y Avg
-0.75
5Y Avg
-0.52
Market Cap
$30.56M
Earnings Per Share (EPS)
-1.84
TTM Avg
-2.44
3Y Avg
-1.37
5Y Avg
-9.44
Market Cap
$29.65M
Earnings Per Share (EPS)
-0.17
TTM Avg
-0.24
3Y Avg
-0.47
5Y Avg
-0.92
Market Cap
$31.12M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.73
3Y Avg
-1.47
5Y Avg
-1.95
Market Cap
$30.00M
Earnings Per Share (EPS)
-3.21
TTM Avg
-2.50
3Y Avg
-4.25
5Y Avg
-9.67
Market Cap
$29.95M
Earnings Per Share (EPS)
-4.31
TTM Avg
-4.75
3Y Avg
-350.99
5Y Avg
-43000.60
Market Cap
$31.44M
Earnings Per Share (EPS)
0.37
TTM Avg
-0.28
3Y Avg
0.68
5Y Avg
0.80
Market Cap
$29.54M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.42
3Y Avg
-0.82
5Y Avg
-1.14
Market Cap
$29.37M
Earnings Per Share (EPS)
-1.87
TTM Avg
-12.30
3Y Avg
-40.98
5Y Avg
-45.74
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MIRA Pharmaceuticals, Inc. (MIRA) | $30.69M | -1.38 | -0.93 | -0.75 | -0.52 |
| SCYNEXIS, Inc. (SCYX)vs › | $30.56M | -1.84 | -2.44 | -1.37 | -9.44 |
| BeyondSpring Inc. (BYSI)vs › | $29.65M | -0.17 | -0.24 | -0.47 | -0.92 |
| MDxHealth S.A. (MDXH)vs › | $31.12M | N/A | -0.73 | -1.47 | -1.95 |
| CervoMed Inc. (CRVO)vs › | $30.00M | -3.21 | -2.50 | -4.25 | -9.67 |
| GridAI Technologies Corp. (GRDX)vs › | $29.95M | -4.31 | -4.75 | -350.99 | -43000.60 |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 0.37 | -0.28 | 0.68 | 0.80 |
| Context Therapeutics Inc. (CNTX)vs › | $29.54M | -0.48 | -0.42 | -0.82 | -1.14 |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | -1.87 | -12.30 | -40.98 | -45.74 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.14M | N/A | -0.24 | -0.01 | 0.39 |
Trailing EPS (TTM)
$-1.38
Forward EPS (Est.)
$-0.12
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.35 |
| 2024-12-31 | -0.51 |
| 2023-12-31 | -0.65 |
| 2022-12-31 | -0.48 |
| 2021-12-31 | -0.15 |
| 2020-12-31 | 0.00 |
